Papers
23
Total Citations
553
H-Index
10
About
James E. Montie is a leading urologic oncologist whose research has fundamentally shaped the modern surgical treatment of prostate cancer, particularly through the lens of technological adoption and patient-centered outcomes. His major contributions center on critically evaluating the rapid dissemination of advanced surgical technologies, such as robotic prostatectomy and intensity-modulated radiotherapy (IMRT). His landmark 2013 study, cited over 140 times, revealed a troubling trend: these expensive, advanced treatments were being widely used even in men at low risk of dying from prostate cancer, raising crucial questions about over-treatment and healthcare value. Montie pioneered innovative methods for assessing surgical quality, including the use of peer and crowd-sourced assessments of technical skill during robot-assisted radical prostatectomy, a concept that has garnered over 110 citations. He has also rigorously compared health outcomes between robotic and conventional surgery, investigated risk factors for post-prostatectomy complications like anastomotic stenoses, and validated patient-reported outcome measures (PROMIS) to ensure that recovery of sexual function is accurately captured. Through his work on certificate of need legislation, Montie has connected surgical practice patterns to health policy, demonstrating a rare ability to bridge clinical urology, health services research, and patient quality of life.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10